Healthcare disruption pivots on cost and AI

Bernstein forecasts a significant disruption in U.S. healthcare, propelled by persistent high costs and the integration of artificial intelligence, projecting a potential trillion-dollar market shift by 2030. This transformation is characterized by four key themes: AI and digital health solutions to lower unit costs, the expansion of value-based care models, enhanced access to specialized services, and innovation in the pharmacy channel. Despite execution and regulatory hurdles, tight margins and flat reimbursement are compelling incumbent healthcare providers to adopt these cost-curve-bending technologies and models.

Analysis

A Bernstein report highlights an impending wave of disruption in the U.S. healthcare sector, driven by persistently high costs and the proliferation of artificial intelligence. The analysis outlines four key themes: AI-driven digital health aimed at lowering unit costs; an accelerated shift to value-based care, projected to become a trillion-dollar market by 2030; improved access to specialized services in areas like behavioral and women's health; and innovation in the pharmacy channel to counter rising drug expenses. Significant capital is flowing into these areas, evidenced by IPOs, private mergers, and strategic acquisitions such as Elevance Health's (ELV) $2.7 billion purchase of CareBridge. This M&A activity signals that incumbents are actively positioning themselves within this new landscape. While execution risks for value-based models and regulatory hurdles for AI present challenges, Bernstein suggests that tight margins and flat reimbursements are creating a powerful incentive for the industry to adopt these cost-curve-bending technologies and business models.

Key Decisions for Investors

• Investors should identify and evaluate pure-play companies, both public and private, that are leaders in the identified disruptive themes of AI-enabled health, value-based care, specialized access, and pharmacy innovation.
• Monitor large-cap incumbents like Elevance Health (ELV) for their M&A strategy, as acquisitions of disruptive players can serve as a key indicator of successful adaptation and a potential catalyst for value creation.
• Recognize that while the long-term growth opportunity is substantial, the noted execution risks and regulatory hurdles necessitate a long-term investment horizon and careful position sizing to account for potential volatility and delays in adoption.